Sotera Health Company (SHC) 의 후행 P/E는 54.9, 선행 P/E 16.5. 후행 이익수익률은 1.82%, 선행 이익수익률 6.05%. PEG 0.80 (Peter Lynch 저평가 ≤1.0). 그레이엄 넘버는 $3.63.
이 페이지에서 입증된 기준:
SharesGrow 종합 점수: 64/100 3/7 개 기준 통과.
| Year | P/E (TTM) | PEG 비율 | P/B 비율 | P/S 비율 | 배당 수익률 |
|---|---|---|---|---|---|
| 2018 | -1,052.5 | 0.00 | 139.28 | 8.28 | 2.85% |
| 2019 | -342.4 | -1.70 | -11.11 | 9.17 | 9.68% |
| 2020 | -201.3 | -2.12 | 17.18 | 9.50 | - |
| 2021 | 56.3 | -0.14 | 11.22 | 7.06 | - |
| 2022 | -10.0 | 0.03 | 6.66 | 2.32 | - |
| 2023 | 92.2 | -0.76 | 10.67 | 4.51 | - |
| 2024 | 87.1 | -7.84 | 9.55 | 3.52 | - |
| 2025 | 64.3 | 0.93 | 8.27 | 4.30 | - |
| Year | EPS (희석) | 매출 | 순이익 | 순이익률 |
|---|---|---|---|---|
| 2018 | $-0.02 | $746.15M | $-5.87M | -0.8% |
| 2019 | $-0.07 | $778.33M | $-20.85M | -2.7% |
| 2020 | $-0.13 | $818.16M | $-38.62M | -4.7% |
| 2021 | $0.41 | $931.48M | $116.88M | 12.5% |
| 2022 | $-0.83 | $1B | $-233.57M | -23.3% |
| 2023 | $0.18 | $1.05B | $51.38M | 4.9% |
| 2024 | $0.16 | $1.1B | $44.4M | 4% |
| 2025 | $0.27 | $1.16B | $77.95M | 6.7% |
| Year | EPS (평균) | EPS 범위 | 매출 (평균) | 매출 범위 | 애널리스트 수 |
|---|---|---|---|---|---|
| 2026 | $0.96 | $0.92 – $0.98 | $1.24B | $1.23B – $1.24B | 5 |
| 2027 | $1.05 | $1.01 – $1.07 | $1.31B | $1.29B – $1.32B | 5 |
| 2028 | $1.18 | $1.09 – $1.26 | $1.39B | $1.39B – $1.39B | 2 |
| 2029 | $1.29 | $1.28 – $1.30 | $1.49B | $1.48B – $1.5B | 1 |
